Gene therapy for metabolic diseases of the liver

BioDrugs

Volumn 13, Issue 3, 2000, Pages 177-188

  Promrat, Kittichai ^a   Wu, George Y ^a   Wu, Catherine H ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GENE PRODUCT; LIPOSOME; RIBOZYME; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ALPHA 1 ANTITRYPSIN DEFICIENCY; CLONING VECTOR; CRIGLER NAJJAR SYNDROME; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HEMOPHILIA A; HEMOPHILIA B; HUMAN; LIVER DISEASE; METABOLIC DISORDER; PRIORITY JOURNAL; RETROVIRUS; REVIEW;

EID: 0034086269     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-200013030-00003     Document Type: Review

References (62)

1. Kalpana GV. Retroviral vectors for liver-directed gene therapy. Semin Liver Dis 1999; 19 (1): 27-37
2. Kafri T, Blomer U, Peterson DA, et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 1997; 17 (3): 314-7
3. Chowdhury JR, Grossman M, Gupta S, et al. Long term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science 1991; 254: 1802-5
4. Grossman M, Raper SE, Kosarsky K, et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolemia. Nat Get 1994; 6: 335-41
5. Tada K, Chowdhury NR, Neufeld D, et al. Long term reduction of serum bilirubin levels in Gunn rats by retroviral gene transfer in vivo. Liver Transplant Surg 1998; 4: 78-88
6. Forbes SJ, Themis M, Alison MR, et al. Retroviral gene transfer to the liver in vivo during tri-iodothyronine induced hyperplasia. Gene Ther 1998 Apr; 5 (4): 552-5
7. Patijn GA, Lieber A, Schowalter DB, et al. Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice. Hepatology 1998 Sep; 28 (3): 707-16
8. Gao C, Jokerst R, Gondipalli P, et al. Intramuscular injection of an adenoviral vector expressing hepatocyte growth factor facilitates hepatic transduction with a retroviral vector in mice. Hum Gene Ther 1999 Apr 10; 10 (6): 911-22
9. Patijn GA, Lieber A, Meuse L, et al. High-efficiency retrovirus mediated gene transfer into livers of mice. Hum Gene Ther 1998 Jul 1; 9 (10): 1449-56
10. Ott M, Stockert RJ, Ma Q. et al. Simultaneous up-regulation of viral receptor expression and DNA synthesis is required for increasing efficiency of retroviral hepatic gene transfer. J Biol Chem 1998 May 8; 273 (19): 11954-61
11. Cai SR, Kennedy SC, Bowling WM, et al. Therapeutic levels of human protein C in rats after retroviral vector-mediated hepatic gene therapy. J Clin Invest 1998 Jun 15; 101 (12): 2831-41
12. Ilan Y, Saito H, Thummala NR, et al. Adenovirus-mediated gene therapy of liver diseases. Semin Liver Dis 1999; 19 (1): 49-59
13. Ilan Y, Jona VK, Sengupta K, et al. Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using rccombinant adenoviruses in the rat. Hepatology 1997; 26: 949-56
14. Kay MA, Meuse L, Gown AM, et al. Transient immunomodulation w ith anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver. Proc Nail Acad Sci U S A 1997 Apr; 94: 4686-91
15. Ilan Y, Sauter B, Chowdhury NR, et al. Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with preexisting immunity to adenoviruses. Hepatology 1998; 27: 1368-76
16. Morsy MA, Gu M, Motzel S, et al. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc Natl Acad Sci U S A 1998 Jul; 95: 7866-71
17. Kafri T, Morgan D, Krahl T, et al. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implication for gene therapy. Proc Natl Acad Sci U S A 1998 Sep; 95: 11377-82
18. Burcin MM, Schiedner G, Kochanek S, et al. Adenovirus-mediated regulable target gene expression in vivo. Proc Natl Acad Sci U S A 1999 Jan; 96 (2): 355-60
19. Gambhir SS, Barrio JR, Phelps MB, et al. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci U S A 1999 Mar; 96 (5): 2333-8
20. Ilan Y, Draguett G, Chowdhury NR, et al. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. Proc Natl Acad Sci U S A 1997; 94: 2587-92
21. Kiwaki K, Kanegae Y, Saito I, et al. Correction of ornithine transcarbamylase deficiency in adult spf(ash) mice and OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter. Hum Gene Ther 1996; 7: 821-30
22. Raper SE, Wilson JM, Yudkoff M, et al. Developing adenoviral-mediated in vivo gene therapy for ornithine transcarbamylase deficiency. J Inher Metab Dis 1998; 21 Suppl. 1: 119-37
23. Lee B, Dennis JA, Healy PJ, et al. Hepatocyte gene therapy in a large animal: a neonatal bovine model of citrullinemia. Proc Natl Acad Sci U S A 1999 Mar; 96 (7): 3981-6
24. Schiedner G, Morral N, Parks RJ, et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 1998 Feb; 18 (2): 180-3
25. Patijn GA, Kay MA. Hepatic gene therapy using adeno-associated virus vectors. Semin Liver Dis 1999; 19 (1): 61-9
26. Summerford C, Samulski RJ. Membrane-associated heparan sulphate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998; 72: 1438-45
27. Qing K, Mah C, Hansen J, et al. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 1999 Jan; 5 (1): 71-7
28. Summerford C, Bartlett JS, Samulski RJ, et al. AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med 1999 Jan; 5 (1): 78-82
29. Koeberl DD, Alexander IE, Halbert CL, et al. Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc Natl Acad Sci U S A 1997 Feb; 94: 1426-31
30. Herzog RW, Hagstrom JN, Kung SH, et al. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc Natl Acad Sci U S A 1997 May; 94: 5804-9
31. Herzog RW, Yang EY, Couto LB, et al. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 1999 Jan; 5 (1): 56-63
32. Snyder RO, Miao C, Meuse L, et al. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med 1999 Jan; 5 (1): 64-70
33. Wang L, Takabe K, Bidlingmaier SM, et al. Sustained correction of bleeding disorder in hemophilia B mice by gene therapy. Proc Natl Acad Sci U S A 1999 Mar; 96: 3906-10
34. Song S, Morgan M, Ellis T, et al. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci U S A 1998 Nov; 95: 14384-8
35. Smith RM, Wu GY. Hepatocyte-directed gene delivery by receptor-mediated endocytosis. Semin Liver Dis; 19 (1): 83-92
36. Pitard B, Oudrhiri N, Vigneron JP, et al. Structural characteristics of supramolecular assemblies formed by guanidinium-cholesterol reagents for gene transfection. Proc Natl Acad Sci U S A 1999 Mar; 96: 2621-6
37. Wu J, Liu P, Zhu JL, et al. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents. Hepatology 1998; 27: 772-8
38. Xing X, Zhang S, Chang JY, et al. Safety study and characterization of E1A-liposome complex gene-delivery protocol in an ovarian cancer model. Gene Ther 1998 Nov; 5 (11): 1538-44
39. Knowles MR, Noone PG, Hohneker K, et al. A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosis. Hum Gene Ther 1998 Jan; 9 (2): 249-69
40. Wu GY, Wu CH. Receptor-mediated gene delivery and expression in vivo. J Biol Chem 1988; 263: 14621-4
41. Wu G, Zhan P, Sze LL, et al. Incorporation of adenovirus into a ligand-based DNA carrier system results in retention of original receptor specificity and enhances target gene expression. J Biol Chem 1994; 269: 11542-6
42. Cristiano RJ, Smith LC, Woo SLC. Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes. Proc Natl Acad Sci USA 1993; 90: 2122-6
43. Uherek C, Fominaya J, Wels W. A modular DNA carrier protein based on the structure of diphtheria toxin mediates target cell-specific gene delivery. J Biol Chem 1998 Apr; 273 (15): 8835-41
44. Chowdhury NR, Hays RM, Bommineni VR, et al. Microtubular disruption prolongs the expression of human bilirubinuridinediphosphoglucuronate-glucurunosyltransferase-1 gene transferred into Gunn rat livers. J Biol Chem 1996; 271: 2341-6
45. Zanta MA, Boussif O, Adib A, et al. In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. Bioconjug Chem 1997; 8: 839-44
46. Bettinger T, Remy JS, Erbacher P. Size reduction of galacto-sylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes. Bioconjug Chem 1999 Jul-Aug; 10 (4): 558-61
47. Perales JC, Grossman GA, Molas M, et al. Biochemical and functional characterization of DNA complexes capable of targeting genes to hepatocytes via the asialoglycoprotein receptor. J Biol Chem 1997 Mar; 272 (11): 7398-407
48. Ziady AC, Perales JC, Ferkol T, et al. Gene transfer into hepatoma cell lines via the serpin enzyme complex receptor. Am J Physiol 1997 Aug; 273 (2 Pt 1): G545-52
49. Cole-Strauss A, Yoon K, Xiang Y, et al. Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide. Science 1996; 273: 1386-9
50. Kren BT, Bandyopadhyay P, Steer CJ. In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat Med 1998 Mar; 4 (3): 285-90
51. Bandyopadhyay P, Ma X, Linehan-Stieers C, et al. Nucleotide exchange in genomic DNA of rat hepatocytes using RNA/DNA oligonucleotides. Targeted delivery of liposomes and polyethylenemine to the asialoglycoprotein receptor. J Biol Chem 1999 Apr 9; 274 (15): 10163-72
52. Cole-Strauss A, Gamper H, Holloman WK, et al. Targeted gene repair directed by the chimeric RNA/DNA oligonucleotide in a mammalian cell-free extract. Nucleic Acids Res 1999 Mar 1; 27 (5): 1323-30
53. Kren BT, Parashar B, Bandyopadhyay P, et al. Correction of the UDP-glucuronosyltransferase gene defect in the Gunn rat model of Crigler-Najjar syndrome type I with a chimeric oligonucleotide. Proc Natl Acad Sci U S A 1999 Aug; 96: 10349-54
54. Sakamoto N, Wu CH, Wu GY. Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by Hammerhead ribozymes. J Clin Invest 1996 Dec; 98 (12): 2720-8
55. Zern MA, Ozaki I, Duan L, et al. A novel SV40-based vector successfully transduces and express an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line. Gene Ther 1999 Jan; 6 (1): 114-20
56. Ozaki I, Zern MA, Liu S, et al. Ribozyme-mediated specific gene replacement of the alpha 1-antitrypsin gene in human hepatoma cells. J Hepatol 1999 Jul; 31 (1): 53-60
57. Wang JP, Enjoji M, Tiebel M, et al. Hammerhead ribozyme cleavage of apolipoprotein B mRNA generates a truncated protein. J Biol Chem 1999 Aug 20; 274 (34): 24161-70
58. Samarsky DA, Ferbeyre G, Bertrand E, et al. A small nucleolar RNA:ribozyme hybrid cleaves a nucleolar RNA target in vivo with near-perfect efficiency. Proc Natl Acad Sci U S A 1999 Jun; 96: 6609-14
59. Nakazono K, Ito Y, Wu CH, et al. Inhibition of hepatitis B virus replication by targeted pretreatment of complexed antisense DNA in vitro. Hepatology 1996; 23: 1297-303
60. Wu CH, Wu GY. Targeted inhibition of hepatitis C virus-directed gene expression in human hepatoma cell lines. Gastroenterology 1998; 114: 1304-12
61. Sugano M, Makino N, Sawada S, et al. Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits. J Biol Chem 1998 Feb 27; 273 (9): 5033-6
62. Qi Z, Atsuchi N, Ooshima A, et al. Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci U S A 1999 Mar; 96: 2345-9